Drug Topics
APRIL 16, 2024
Findings indicating that socioeconomic disparities widened gaps in vaccination timeliness signal the need for increased efforts to promote timely vaccination among children from families with lower income and those without private insurance.
PharmaVoice
APRIL 16, 2024
New clinical trial starts are picking back up, but are still far below their bustling pre-war level.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
APRIL 16, 2024
With the judge’s failure to approve a settlement class, a $13.5 million settlement against Eli Lilly was called off.
Pharmacy Times
APRIL 16, 2024
The campaign for National Stress Awareness Month in April is under way.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
APRIL 16, 2024
The DEA informed community pharmacists on e-prescribing fraud and measures necessary to detect it.
STAT
APRIL 16, 2024
In the first federal hearing focused on the massive cyberattack on Change Healthcare , lawmakers had many important questions for UnitedHealth, which owns Change: Did it meet Health and Human Services’ cybersecurity performance goals ? Has UnitedHealth exploited physicians’ cash shortfalls caused by the Change outage to acquire struggling practices?
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
APRIL 16, 2024
WASHINGTON – In the last decade, Americans have been sickened by salmonella from cucumbers, listeria from Mexican-style cheese, and E. coli from romaine lettuce. Now, it would seem that Washington is finally getting serious about making sure the Food and Drug Administration has the power to promptly investigate and respond to foodborne outbreaks.
Drug Topics
APRIL 16, 2024
A study from the Karolinska Institutet found that 76 out of 145410 patients treated with a GLP-1 developed thyroid cancer during nearly 4 years of follow-up.
STAT
APRIL 16, 2024
The face of autism was once predominantly white. No longer. The Centers for Disease Control and Prevention reported last year that the prevalence of autism across all racial and ethnic groups is reaching parity. Among 8-year-olds in particular, autism was more commonly identified among Black, Hispanic and Asian American/Pacific Islander children than among their white counterparts for the first time ever.
Drug Topics
APRIL 16, 2024
April showers might bring May flowers, but for some, the month also brings the return of allergy woes. This spring, breathe easy with these OTC allergy product recommendations.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
APRIL 16, 2024
WASHINGTON — President Joe Biden’s administration will help 50 countries identify and respond to infectious diseases, with the goal of preventing pandemics like the Covid-19 outbreak that suddenly halted normal life around the globe in 2020. U.S. government officials will offer support in the countries, most of them located in Africa and Asia , to develop better testing, surveillance, communication, and preparedness for such outbreaks in those countrie
Fierce Healthcare
APRIL 16, 2024
UnitedHealth Group released its first-quarter earnings Tuesday morning as the industry continues to reel from the massive cyberattack on its Change Healthcare unit. | UnitedHealth Group released its first-quarter earnings Tuesday morning as the industry continues to reel from the massive cyberattack on its Change Healthcare unit.
pharmaphorum
APRIL 16, 2024
A smart sensor developed by Adherium has been cleared by the FDA for use with AstraZeneca's asthma inhaler Airsupra and Breztri for COPD.
Fierce Healthcare
APRIL 16, 2024
The House Energy & Commerce subcommittee on innovation will hold a hearing Wednesday to discuss data privacy and the protection of kids online. | The House Energy & Commerce Committee holds a legislative hearing to discuss a slate of privacy and online safety bills Wednesday, one of which would give consumers more control over health data collected by apps and big tech.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
APRIL 16, 2024
The study is the first of 5 studies co-published by AYR Wellness and LECOM and showcases improvements in physical, social, and mental well-being with minimal AEs.
pharmaphorum
APRIL 16, 2024
Researchers from the UK have developed an endoscopic device that uses 3D imaging to look at the stiffness of cells and could diagnose cancer earlier.
STAT
APRIL 16, 2024
Most people know silica as the mysterious contents of desiccation packets found in vitamin bottles, high-end leather purses, clothing, and other items. But for miners and other stone cutters, silica is a serious health hazard, and new rules announced on Tuesday by a U.S. government agency set strict limits on how much of the mineral they can be exposed to.
Pharmacy Times
APRIL 16, 2024
Sa’ed Al-Olimat, PharmD, co-founder of the Psychedelic Pharmacists Association, discussed the future of psychedelic medicines and the unique ethical challenges they present.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
APRIL 16, 2024
Hospitals and medical groups say they’re still reeling from the effects of the cyberattack on a UnitedHealth Group subsidiary, but the massive company at the center of the debacle has so far emerged largely unscathed, with executives on Tuesday praising its strength and resilience. The almost $8 billion UnitedHealth made on operations in the first three months of 2024 was roughly the same as the prior-year period.
pharmaphorum
APRIL 16, 2024
Boehringer Ingelheim says the strongest R&D pipeline in its history is set to deliver 25 new product launches between now and 2030
STAT
APRIL 16, 2024
Intra-Cellular Therapies reported positive results Tuesday from a late-stage clinical trial seeking to expand the use of its antipsychotic medicine Caplyta to patients with major depressive disorder. In the Phase 3 study, Caplyta reduced depressive symptoms by 4.9 points compared to a placebo on the Montgomery-Asberg Depression Rating Scale (MADRS), a widely used, clinician-rated measure of depression severity.
Pharmacy Times
APRIL 16, 2024
The latest FDA approval paves the way for expanded use of GLP-1 receptor agonists in patients without diabetes.
STAT
APRIL 16, 2024
“You have a big voice, Dr. Grubbs,” the clinic manager said. I flinched. The last time I heard similar words, they were part of a common refrain that I had encountered often. “You’re too direct.” “Too outspoken.” “Intimidating.” Peers who looked like me encouraged me to put my head down, make myself smaller, endure — and never, ever call out racism.
Fierce Pharma
APRIL 16, 2024
Despite a pair of clinical misfires in 2023, argenx has stuck by the thesis that its star drug Vyvgart, also known as efgartigimod, could tackle a wide array of autoimmune diseases linked to immuno | Argenx is bolstering its case for Vyvgart’s CIDP potential and preparing for a possible launch later this year—all while the company continues to prove the medication’s worth in its inaugural generalized myasthenia gravis indication.
Pharmaceutical Technology
APRIL 16, 2024
Norgine has sought approval for eflornithine (DFMO) for the treatment of patients with high-risk neuroblastoma (HRNB).
pharmaphorum
APRIL 16, 2024
FDA starts review of GSK’s 5-in-1 meningitis vaccine, cueing up a decision early next year, as it tries to chase down Pfizer's recently-approved Penbraya
Pharmaceutical Technology
APRIL 16, 2024
The price ceiling policy has been in place for more than 20 years, but it has neither been very successful nor free of consequences for pharma companies.
Pharmacy Times
APRIL 16, 2024
AI offers many benefits in health professions by efficiently handling time-consuming tasks crucial for patient care.
STAT
APRIL 16, 2024
The fairness of PIPEs, particularly the preferential sharing of confidential, stock-moving information, is now a legal question. A shareholder is suing Taysha Gene Therapies insiders and a group of health care investment firms for allegedly enriching themselves in a $150 million PIPE transaction that involved delaying the public disclosure of positive results from a gene therapy clinical trial.
Fierce Pharma
APRIL 16, 2024
Intra-Cellular Therapies has unveiled another positive late-stage trial readout for Caplyta, taking another step toward a potential blockbuster label expansion for the depression drug. | Intra-Cellular Therapies has unveiled another positive late-stage trial readout for Caplyta, taking another step toward a potential blockbuster label expansion for the depression drug.
STAT
APRIL 16, 2024
Top of the morning to you, and a fine one it is. Clear blue skies and cool breezes are currently enveloping the placid Pharmalot campus, where the official mascots are snoozing cozily in their respective corners and the usual din of motor cars is nowhere to be heard. So this calls for a celebratory cup of stimulation. Our choice today is the oh-so tasty hazelnut mocha.
PioneerRx
APRIL 16, 2024
It’s the most wonderful time of year for PioneerRx. Catalyst Connect 2024 is rapidly approaching, where pharmacists and other healthcare professionals.
STAT
APRIL 16, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! Today, we dig into Biohaven’s plans and see Humira biosimilar prescriptions shoot up.
Expert insights. Personalized for you.
386 
Let's personalize your content